Eventide Asset Management’s Regulus Therapeutics RGLS Stock Holding History

Eventide Asset Management’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,338	Closed	-$1.4M	–	142
2015 Q4	$1.4M	Hold	1,338	–	–	0.07%	105
2015 Q3	$1.05M	Hold	1,338	–	–	0.06%	106
2015 Q2	$1.76M	Buy	1,338 +371	+38%	+$599K	0.1%	100
2015 Q1	$1.97M	Buy	967 +467	+93%	+$1.01M	0.15%	95
2014 Q4	$962K	Buy	+500	New	+$889K	0.11%	97

Other funds holding RGLS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return